tiprankstipranks
Avalo Therapeutics receives $69.4M in proceeds from exercise of warrants
PremiumThe FlyAvalo Therapeutics receives $69.4M in proceeds from exercise of warrants
3M ago
Avalo Therapeutics reports Q3 EPS ($2.83) vs ($22.83) last year
Premium
The Fly
Avalo Therapeutics reports Q3 EPS ($2.83) vs ($22.83) last year
3M ago
Avalo Therapeutics, Inc. (AVTX) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Avalo Therapeutics, Inc. (AVTX) Q3 Earnings Cheat Sheet
3M ago
Avalo Therapeutics trading halted, volatility trading pause
PremiumThe FlyAvalo Therapeutics trading halted, volatility trading pause
5M ago
Avalo Therapeutics Shareholders Back Board and Strategies
Premium
Company Announcements
Avalo Therapeutics Shareholders Back Board and Strategies
6M ago
Avalo Therapeutics sees cash runway into 2027
Premium
The Fly
Avalo Therapeutics sees cash runway into 2027
6M ago
Avalo Therapeutics Welcomes New Chief Legal Officer Paul Varki
PremiumCompany AnnouncementsAvalo Therapeutics Welcomes New Chief Legal Officer Paul Varki
7M ago
Avalo Therapeutics announces Paul Varki joins as Chief Legal Officer
Premium
The Fly
Avalo Therapeutics announces Paul Varki joins as Chief Legal Officer
7M ago
Avalo Therapeutics files to sell 22.36M shares of common stock for holders
Premium
The Fly
Avalo Therapeutics files to sell 22.36M shares of common stock for holders
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100